About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Washington | 1,247 Studies

Clinical Trials Breast CancerWashington

Breast Cancer Clinical Trials in Washington

Find 1,247 clinical trials for breast cancer near Washington. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Washington

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 261-280 of 1,247 trials

CompletedVorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor TherapyThis pilot clinical trial studies vorinostat in treating patients with stage IV breast cancer receiving aromatase inhibitor (AI) therapy.NCT01153672·Seattle, Washington CompletedPhase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast CancerThis phase II trial studies how well 3'-deoxy-3'-18F fluorothymidine (18F-FLT) positron emission tomography (PET)/computed tomography (CT) works in predicting response in patients…NCT00572728·Scottsdale, Arizona and 26 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedPECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast SurgeryIn this double blinded randomized placebo-controlled trial, 160 subjects scheduled for breast surgery involving the axilla will be administered a multimodal pain regimen including…NCT03084536·St Louis, Missouri

TerminatedA Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/RibociclibThis study was a companion study to CLEE011A2404 which provided the opportunity for the collection of tumor tissue samples to better understand relevant mutations and the…NCT03050398·Sedona, Arizona and 5 others

TerminatedGenetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ MalignanciesThis phase I trial studies the side effects and best dose of genetically modified T-cell therapy in treating patients with receptor tyrosine kinase-like orphan receptor 1 positive…NCT02706392·Seattle, Washington

RecruitingPhase 1/2 Study of ETX-636 in Participants With Advanced Solid TumorsPhase 1/2, open-label study of ETX-636 in participants with advanced solid tumorsNCT06993844·Newport Beach, California and 14 others

CompletedVaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in RemissionThis phase I trial studies the side effects and best dose of a vaccine therapy in preventing cancer from coming back in patients with non-metastatic, node positive, human…NCT02780401·Seattle, Washington and 1 other

CompletedStandard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for CancerRATIONALE: Telephone counseling by trained counselors may enhance the well-being and quality of life of patients who have undergone stem cell transplantation for cancer.NCT00049465·Stanford, California and 8 others

RecruitingStudy of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 AlterationThe purpose of this study is to establish the recommended Phase 2 dose (RP2D) and/or maximum tolerated dose (MTD), safety, pharmacokinetics (PK), pharmacodynamics (PD), and…NCT05315700·Duarte, California and 41 others

CompletedA Study of Tucatinib (ONT-380) Combined With Capecitabine and/or Trastuzumab in Patients With HER2+ Metastatic Breast CancerThe purpose of this study is to determine the maximal tolerated dose (MTD) or recommended phase 2 dose (RP2D) of tucatinib (ONT-380) and to assess the safety and tolerability of…NCT02025192·Aurora, Colorado and 4 others

CompletedPyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other CancerRATIONALE: Pyridoxine (vitamin B6) and topical urea/lactic acid-based cream may prevent or lessen hand-foot syndrome caused by chemotherapy.NCT00296036·Scottsdale, Arizona and 230 others

CompletedStudy Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast CancerThis study evaluated and compared the efficacy and tolerability of lapatinib and letrozole, with letrozole and placebo in post-menopausal women with hormone receptor positive (ER…NCT00073528·Tucson, Arizona and 277 others

CompletedAssessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission TomographyThe purpose of this study is to evaluate the uptake of a radioactive tracer 21-18F-fluoro-16α,17α-\[(R)-(1'-α-furylmethylidene)dioxy\]-19-norpregn-4-ene-3,20-dione (FFNP) uptake…NCT02455453·St Louis, Missouri

CompletedStudy Evaluating HKI-272 in TumorsThe purpose of this study is to evaluate the safety and tolerability as well as find the maximum tolerated dose (MTD) for HKI-272.NCT00146172·Tampa, Florida and 4 others

CompletedTranscranial Direct Current Stimulation (tDCS) to Improve Fatigue and Cognitive FunctionThis research is being done to determine whether transcranial direct current stimulation (tDCS) can improve fatigue and certain thinking skills in women with breast cancer…NCT03487601·Washington D.C., District of Columbia and 1 other

CompletedCombination Chemotherapy in Treating Women With Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00003519·Birmingham, Alabama and 133 others

Active not recruitingT-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD TrialThis phase III trial compares the effect of usual treatment with trastuzumab emtansine (T-DM1) alone vs. T-DM1 in combination with tucatinib.NCT04457596·Birmingham, Alabama and 1175 others

TerminatedMGC018 With or Without MGA012 in Advanced Solid TumorsThe purpose of this study is to evaluate the safety and tolerability, pharmacokinetics (PK) pharmacodynamics and preliminary antitumor activity of vobramitamab duocarmazine…NCT03729596·Santa Monica, California and 20 others

Active not recruitingStudy to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid TumorsThe study will determine the recommended Phase 2 dose (RP2D) of livmoniplimab (ABBV-151) administered as monotherapy and in combination with budigalimab (ABBV-181) as well as to…NCT03821935·Springdale, Arkansas and 63 others

CompletedCombination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast CancerThis phase II trial studies how well giving combination chemotherapy and peripheral blood stem cell transplant followed by aldesleukin and sargramostim works in treating patients…NCT00003199·Seattle, Washington

PreviousPage 14 of 63Next

Other Conditions in Washington

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma